Open AccessPegylated Interferon Alfa‐2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C
Author(s) -
ChenHua Liu,
ChengChao Liang,
ChunJen Liu,
JouWei Lin,
ShihI Chen,
PeirHaur Hung,
HungBin Tsai,
Ming–Yang Lai,
PeiJer Chen,
DingShinn Chen,
JiaHorng Kao
Publication year - 2010
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/655682
Subject(s) - medicine , hemodialysis , pegylated interferon , hepatitis c virus , hepatitis c , gastroenterology , interferon , ribavirin , intensive care medicine , immunology , virus
Hemodialysis patients are at risk of hepatitis C virus (HCV) infection. However, little is known about the efficacy and safety of pegylated interferon (IFN) therapy for hemodialysis patients with acute hepatitis C.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom